FDA Anti-Infective Drugs Advisory Committee
Executive Summary
Will meet in closed session Jan. 28 to review trade secret and/or confidential information of a pending IND. The closed session, scheduled from 11:00 a.m. to 5:00 p.m., will be preceded by an open public hearing that is scheduled to begin at 10:00 a.m. The meeting will be held in Conference Room E of FDA's Parklawn building.